Why the study?
Does polypharmacy increase the risk of premature death in older adults?
Does polypharmacy increase the risk of premature death in older adults?
Polypharmacy is associated with a significantly increased mortality risk among older adults, highlighting the need to evaluate medication appropriateness.
May warrant medication review in older adults; leaves open causality and intervention effects.
A considerable proportion of older adults in Denmark were exposed to polypharmacy dependent on health status, socio-economic status, and societal factors. The associated three- to four-fold mortality risk indicate a need for further exploration of the appropriateness of polypharmacy among older adults.
No takes yet. Share an insight, caveat, or question.
Pallesen et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: